Cancer drug is first to alleviate devastating scleroderma symptoms

Scleroderma is a debilitating autoimmune disease that attacks the connective tissues and especially the lungs. Hardening of the skin is one of the most visible effects of the disease. Over 40 percent of patients will develop symptomatic lung problems the leading cause of death for scleroderma patients.

A new nationwide study headed by UCLA found that a drug used for cancer called cyclophosphamide, helped alleviate the serious effects of scleroderma on breathing, lung function, quality of life, functional disability and skin thickness. This is the first controlled clinical trial to show a positive treatment for scleroderma lung disease.

Findings will help researchers develop new drug therapies and also better understand development of the disease. The next step is further research into use of cylophosphamide as well as other immunosuppressant drugs.

Drs. Donald Tashkin and Michael Roth, professors of pulmonary and critical care medicine; and Drs. Philip Clements and Daniel Furst, professors of rheumatology, David Geffen School of Medicine at UCLA.


Contact: Rachel Champeau
University of California - Los Angeles

Page: 1

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:

(Date:10/10/2015)... Concord, NC (PRWEB) , ... October 10, 2015 , ... ... Charlotte Motor Speedway in Concord, NC. Saturday, October 10th, defending race winner, ... Johnson, Joey Logano, Matt Kenseth, Dale Earnhardt Jr., and all of the stars of ...
(Date:10/10/2015)... (PRWEB) , ... October 10, 2015 , ... In the ... been named the Best Place To Work in Jacksonville, amongst medium-sized companies with 25 ... 27th and was followed up with a celebratory gala on October 1st. , ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... With the ... color pop grades to footage. A LUT is a Lookup Table that contains a ... corresponding color indicated by the table. This pack comes with 60 vibrant CUBE LUT ...
(Date:10/9/2015)... , ... October 09, 2015 , ... ... a special promotion on Invisalign, the orthodontic system that uses clear, plastic aligners. ... are almost invisible against the teeth, which allow patients to complete treatment in ...
(Date:10/9/2015)... ... October 09, 2015 , ... Confidence Plus ... program, a community improvement initiative that involves working with a series of local ... assistance of Confidence Plus Insurance is the Gleason Park Electric Violin Ensemble (GPEVE). ...
Breaking Medicine News(10 mins):
(Date:10/8/2015)... ® ) in adult ... NOCT study also assessed the compliance, safety, patient ... ® ) in adult patients undergoing screening, surveillance ... the compliance, safety, patient acceptability and tolerability of ... top line results for its phase III study, ...
(Date:10/8/2015)... , Oct. 8, 2015  "They really did surround ... her Kaiser Permanente care team, after a routine appointment ... plan for cancer. The 79-year-old Kaiser Permanente Senior Advantage ... went in for what she thought was tendinitis from ... and care team, however, she was diagnosed with and ...
(Date:10/8/2015)... HERTFORDSHIRE, England and PITTSBURGH ... MYL ), a leading global pharmaceutical company, will host ... th at 5:00 pm ET to review the ... plc (NYSE: PRGO ; TASE) through Mylan,s offer ... review a comprehensive presentation which outlines the compelling proposition ...
Breaking Medicine Technology:
Cached News: